The agency stated that scientists from Tsinghua University in Beijing, in cooperation with a hospital in Shenzhen, and the company “Pre Biosciences”, succeeded in developing a new treatment that is given by injection, and is based on “monoclonal” antibodies, which adhere to the protein of the virus and reduce the risk of infection. Its ability to enter human cells.
The agency indicated that clinical trials showed that the treatment contributes to reducing hospital admission rates and the risk of death in patients with weak immunity by 80%, stressing that the treatment was used on patients who were infected during the recent wave of the epidemic.
These were the details of the news China approves first anti-coronavirus drug “Covid-19” for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
